Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins
- PMID:9351897
Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins
Abstract
Grapefruit juice increases the oral availability of a variety of CYP3A4 substrates. It has been shown that recurrent grapefruit juice ingestion results in a loss of CYP3A4 from the small bowel epithelium. We now show that the reduction in intestinal CYP3A4 concentration is rapid; a 47% decrease occurred in a healthy volunteer within 4 hr after consuming grapefruit juice. To identify the specific components of the juice responsible for this effect, we used a recently developed Caco-2 cell culture model of human intestinal epithelium that expresses catalytically active CYP3A4. We found that grapefruit oil and two furanocoumarin constituents (6', 7'-dihydroxybergamottin and a closely related dimer) caused a dose-dependent fall in CYP3A4 catalytic activity and immunoreactive CYP3A4 concentration. The effect was selective in that concentrations of CYP1A1 and CYP2D6 did not fall, consistent with previous results obtained in vivo. Assays of various juices confirmed that 6',7'-dihydroxybergamottin is the major furanocoumarin present and, although its concentration varies significantly among types and brands of grapefruit juice, it is consistently present in concentrations exceeding the IC50 (1 microM) for loss of midazolam 1'-hydroxylase activity determined in the Caco-2 cells. Studies with recombinant CYP3A4 revealed that 6', 7'-dihydroxybergamottin is a mechanism-based inactivator, which supports the idea that loss of CYP3A4 results from accelerated degradation of the enzyme. We conclude that the effect of grapefruit juice on oral availability of CYP3A4 substrates can be largely accounted for by the presence of 6',7'-dihydroxybergamottin although other furanocoumarins probably also contribute.
Similar articles
- 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.Edwards DJ, Fitzsimmons ME, Schuetz EG, Yasuda K, Ducharme MP, Warbasse LH, Woster PM, Schuetz JD, Watkins P.Edwards DJ, et al.Clin Pharmacol Ther. 1999 Mar;65(3):237-44. doi: 10.1016/S0009-9236(99)70102-5.Clin Pharmacol Ther. 1999.PMID:10096255Clinical Trial.
- Seville orange juice-felodipine interaction: comparison with dilute grapefruit juice and involvement of furocoumarins.Malhotra S, Bailey DG, Paine MF, Watkins PB.Malhotra S, et al.Clin Pharmacol Ther. 2001 Jan;69(1):14-23. doi: 10.1067/mcp.2001.113185.Clin Pharmacol Ther. 2001.PMID:11180034Clinical Trial.
- Inhibition selectivity of grapefruit juice components on human cytochromes P450.Tassaneeyakul W, Guo LQ, Fukuda K, Ohta T, Yamazoe Y.Tassaneeyakul W, et al.Arch Biochem Biophys. 2000 Jun 15;378(2):356-63. doi: 10.1006/abbi.2000.1835.Arch Biochem Biophys. 2000.PMID:10860553
- Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines.Guo LQ, Yamazoe Y.Guo LQ, et al.Acta Pharmacol Sin. 2004 Feb;25(2):129-36.Acta Pharmacol Sin. 2004.PMID:14769198Review.
- Drug interactions with grapefruit juice. Extent, probable mechanism and clinical relevance.Fuhr U.Fuhr U.Drug Saf. 1998 Apr;18(4):251-72. doi: 10.2165/00002018-199818040-00002.Drug Saf. 1998.PMID:9565737Review.
Cited by
- Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs.Zhou S, Yung Chan S, Cher Goh B, Chan E, Duan W, Huang M, McLeod HL.Zhou S, et al.Clin Pharmacokinet. 2005;44(3):279-304. doi: 10.2165/00003088-200544030-00005.Clin Pharmacokinet. 2005.PMID:15762770Review.
- Effects of subacutely administered saiboku-to, an oriental herbal medicine, on pharmacodynamics and pharmacokinetics of diazepam in rodents.Yuzurihara M, Ikarashi Y, Ishihara K, Kushida H, Ishige A, Sasaki H, Maruyama Y.Yuzurihara M, et al.Eur J Drug Metab Pharmacokinet. 2000 Apr-Jun;25(2):127-36. doi: 10.1007/BF03190079.Eur J Drug Metab Pharmacokinet. 2000.PMID:11112094
- Grapefruit juice reduces the oral bioavailability of fexofenadine but not desloratadine.Banfield C, Gupta S, Marino M, Lim J, Affrime M.Banfield C, et al.Clin Pharmacokinet. 2002;41(4):311-8. doi: 10.2165/00003088-200241040-00004.Clin Pharmacokinet. 2002.PMID:11978146Clinical Trial.
- Hepatic cytochrome P450 ubiquitination: conformational phosphodegrons for E2/E3 recognition?Correia MA, Wang Y, Kim SM, Guan S.Correia MA, et al.IUBMB Life. 2014 Feb;66(2):78-88. doi: 10.1002/iub.1247. Epub 2014 Feb 3.IUBMB Life. 2014.PMID:24488826Free PMC article.Review.
- Stable isotope-labelled intravenous microdose for absolute bioavailability and effect of grapefruit juice on ibrutinib in healthy adults.de Vries R, Smit JW, Hellemans P, Jiao J, Murphy J, Skee D, Snoeys J, Sukbuntherng J, Vliegen M, de Zwart L, Mannaert E, de Jong J.de Vries R, et al.Br J Clin Pharmacol. 2016 Feb;81(2):235-45. doi: 10.1111/bcp.12787. Epub 2016 Jan 15.Br J Clin Pharmacol. 2016.PMID:26382728Free PMC article.Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources